Top 10 Spatial Biology Companies
Federal policy turmoil helps deflate revenues for four of the top five publicly traded instrument developers, though private companies keep raising capital as investor interest grows.
Spatial Companies: Up & Comers 2026
Here are 10 “Up & Comers” spatial biology companies that are not large enough to be ranked as public or private companies, but warrant mention based on recent financings, collaborations, new products, attention in peer-reviewed publications, and other developments.
Top 10 Contract Development and Manufacturing Organizations 2026
Alex Philippidis analyzes the top CDMOs this year, noting a bright future as biopharma is expected to increase their reliance on CDMOs in coming years despite rising costs for their services. Which companies made the top 10 list? Check out the list to find out.
GEN Digital Edition
Access the latest issue of GEN and browse the archive of back issues when you subscribe to our digital edition.
Spatial Proteomics for Precision Oncology
In this Monday’s GEN webinar, Bernd Bodenmiller, PhD (University of Zürich), illustrates this integrated approach through two recent examples.
Bernd Bodenmiller, PhD
Associate Professor
Dept. of Quantitative Biomedicine
University of Zürich
ETH Zürich, Switzerland
How Preclinical Manufacturing Can De-Risk the Path to GMP-Ready Viral Vector Programs
Bridging the Translational Gap in Pancreatic Cancer Through Biology-First Modeling
Single-Cell Multiomics: Phenotypic Plasticity in Colorectal Cancer Metastasis
The Aging Proteome: Clocks, Cohorts, and Clinical Trials
Podcast
Touching Base
Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, Uduak Thomas, Corinna Singleman, and Fay Lin—who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what’s now and next. Start listening today!
Stay up to date with the lasted episodes of Touching Base by subscribing to the GEN Podcast Newsletter
StockWatch: Nurix Nosedives as Sanofi Halts Phase I Immunology Candidate
Novartis Confirms Nine Cases of Tumors in Children Treated with Gene Therapy Zolgensma
